Advertisement
UK markets close in 3 hours 34 minutes
  • FTSE 100

    7,840.71
    -36.34 (-0.46%)
     
  • FTSE 250

    19,291.57
    -159.10 (-0.82%)
     
  • AIM

    741.60
    -3.69 (-0.50%)
     
  • GBP/EUR

    1.1676
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2443
    +0.0004 (+0.03%)
     
  • Bitcoin GBP

    52,255.45
    +1,800.87 (+3.57%)
     
  • CMC Crypto 200

    1,339.70
    +27.08 (+2.11%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    82.26
    -0.47 (-0.57%)
     
  • GOLD FUTURES

    2,393.30
    -4.70 (-0.20%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,735.12
    -102.28 (-0.57%)
     
  • CAC 40

    8,012.43
    -10.83 (-0.13%)
     

2 Upcoming FDA Approval Decisions That Investors Should Really Watch

In this Motley Fool Live video recorded on Oct. 13, Fool contributors Keith Speights and Brian Orelli discuss two upcoming U.S. Food and Drug Administration (FDA) approval decisions that investors should keep an eye on. Keith Speights: Brian, on another note, the FDA is set to make several important approval decisions in the fourth quarter. Brian Orelli: Biomarin (NASDAQ: BMRN) has one coming up on Nov. 20.